ID   GCDH_HUMAN              Reviewed;         438 AA.
AC   Q92947; A8K2Z2; O14719;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   15-MAR-2017, entry version 181.
DE   RecName: Full=Glutaryl-CoA dehydrogenase, mitochondrial;
DE            Short=GCD;
DE            EC=1.3.8.6;
DE   Flags: Precursor;
GN   Name=GCDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RC   TISSUE=Liver;
RX   PubMed=1438360;
RA   Goodman S.I., Kratz L.E., Frerman F.E.;
RT   "Pork and human cDNAs encoding glutaryl-CoA dehydrogenase.";
RL   Prog. Clin. Biol. Res. 375:169-173(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT), FUNCTION,
RP   CATALYTIC ACTIVITY, AND VARIANT GA1 HIS-295.
RC   TISSUE=Liver;
RX   PubMed=8541831; DOI=10.1093/hmg/4.9.1493;
RA   Goodman S.I., Kratz L.E., Digiulio K.A., Biery B.J., Goodman K.E.,
RA   Isaya G., Frerman F.E.;
RT   "Cloning of glutaryl-CoA dehydrogenase cDNA, and expression of wild
RT   type and mutant enzymes in Escherichia coli.";
RL   Hum. Mol. Genet. 4:1493-1498(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GA1.
RX   PubMed=9600243; DOI=10.1007/s004390050720;
RA   Schwartz M., Christensen E., Superti-Furga A., Brandt N.J.;
RT   "The human glutaryl-CoA dehydrogenase gene: report of intronic
RT   sequences and of 13 novel mutations causing glutaric aciduria type
RT   I.";
RL   Hum. Genet. 102:452-458(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6423663; DOI=10.1172/JCI111271;
RA   Hyman D.B., Tanaka K.;
RT   "Specific glutaryl-CoA dehydrogenating activity is deficient in
RT   cultured fibroblasts from glutaric aciduria patients.";
RL   J. Clin. Invest. 73:778-784(1984).
RN   [10]
RP   REVIEW ON VARIANTS.
RX   PubMed=9711871;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:3<141::AID-HUMU1>3.0.CO;2-K;
RA   Goodman S.I., Stein D.E., Schlesinger S., Christensen E., Schwartz M.,
RA   Greenberg C.R., Elpeleg O.N.;
RT   "Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I):
RT   review and report of thirty novel mutations.";
RL   Hum. Mutat. 12:141-144(1998).
RN   [11]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17176108; DOI=10.1021/bi0609016;
RA   Rao K.S., Albro M., Dwyer T.M., Frerman F.E.;
RT   "Kinetic mechanism of glutaryl-CoA dehydrogenase.";
RL   Biochemistry 45:15853-15861(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 47-438 IN COMPLEXES WITH
RP   SUBSTRATE ANALOG AND FAD, AND SUBUNIT.
RX   PubMed=15274622; DOI=10.1021/bi049290c;
RA   Fu Z., Wang M., Paschke R., Rao K.S., Frerman F.E., Kim J.-J.P.;
RT   "Crystal structures of human glutaryl-CoA dehydrogenase with and
RT   without an alternate substrate: structural bases of dehydrogenation
RT   and decarboxylation reactions.";
RL   Biochemistry 43:9674-9684(2004).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 45-438 OF MUTANT ASP-414 IN
RP   COMPLEXES WITH SUBSTRATE AND FAD.
RX   PubMed=18020372; DOI=10.1021/bi7009597;
RA   Rao K.S., Fu Z., Albro M., Narayanan B., Baddam S., Lee H.-J.K.,
RA   Kim J.-J.P., Frerman F.E.;
RT   "The effect of a Glu370Asp mutation in glutaryl-CoA dehydrogenase on
RT   proton transfer to the dienolate intermediate.";
RL   Biochemistry 46:14468-14477(2007).
RN   [17]
RP   VARIANTS GA1.
RX   PubMed=8900227;
RA   Biery B.J., Stein D.E., Morton D.H., Goodman S.I.;
RT   "Gene structure and mutations of glutaryl-coenzyme A dehydrogenase:
RT   impaired association of enzyme subunits that is due to an A421V
RT   substitution causes glutaric acidemia type I in the Amish.";
RL   Am. J. Hum. Genet. 59:1006-1011(1996).
RN   [18]
RP   VARIANTS GA1 ARG-101; PRO-283; THR-293; LEU-305; ARG-390 AND ILE-416.
RX   PubMed=8900228;
RA   Anikster Y., Shaag A., Joseph A., Mandel H., Ben-Zeev B.,
RA   Christensen E., Elpeleg O.N.;
RT   "Glutaric aciduria type I in the Arab and Jewish communities in
RT   Israel.";
RL   Am. J. Hum. Genet. 59:1012-1018(1996).
RN   [19]
RP   VARIANT GA1 VAL-263.
RX   PubMed=14707522; DOI=10.1023/B:BOLI.0000005604.90621.e2;
RA   Muehlhausen C., Christensen E., Schwartz M., Muschol N., Ullrich K.,
RA   Lukacs Z.;
RT   "Severe phenotype despite high residual glutaryl-CoA dehydrogenase
RT   activity: a novel mutation in a Turkish patient with glutaric aciduria
RT   type I.";
RL   J. Inherit. Metab. Dis. 26:713-714(2003).
RN   [20]
RP   CHARACTERIZATION OF VARIANTS GA1 GLY-138; TRP-402 AND LYS-414, AND
RP   SUBUNIT.
RX   PubMed=18775954; DOI=10.1093/hmg/ddn284;
RA   Keyser B., Muehlhausen C., Dickmanns A., Christensen E., Muschol N.,
RA   Ullrich K., Braulke T.;
RT   "Disease-causing missense mutations affect enzymatic activity,
RT   stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH).";
RL   Hum. Mol. Genet. 17:3854-3863(2008).
RN   [21]
RP   VARIANTS GA1 ASP-64; VAL-268; ARG-375; TRP-402 AND MET-429.
RX   PubMed=24973495; DOI=10.1016/j.clinbiochem.2014.06.017;
RA   Georgiou T., Nicolaidou P., Hadjichristou A., Ioannou R.,
RA   Dionysiou M., Siama E., Chappa G., Anastasiadou V., Drousiotou A.;
RT   "Molecular analysis of Cypriot patients with Glutaric aciduria type I:
RT   Identification of two novel mutations.";
RL   Clin. Biochem. 47:1300-1305(2014).
CC   -!- FUNCTION: Catalyzes the oxidative decarboxylation of glutaryl-CoA
CC       to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine,
CC       L-hydroxylysine, and L-tryptophan metabolism. It uses electron
CC       transfer flavoprotein as its electron acceptor. Isoform Short is
CC       inactive. {ECO:0000269|PubMed:17176108,
CC       ECO:0000269|PubMed:6423663, ECO:0000269|PubMed:8541831}.
CC   -!- CATALYTIC ACTIVITY: Glutaryl-CoA + electron-transfer flavoprotein
CC       = crotonyl-CoA + CO(2) + reduced electron-transfer flavoprotein.
CC       {ECO:0000269|PubMed:8541831}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- ENZYME REGULATION: Strongly inhibited by MCPA-CoA, a metabolite of
CC       hypoglycin which is present in unripened fruit of the ackee tree.
CC       {ECO:0000269|PubMed:6423663}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.7 uM for glutaryl-CoA (at pH 6.5)
CC         {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663};
CC         KM=5.5 uM for glutaryl-CoA (at pH 7.5)
CC         {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663};
CC         KM=8.1 uM for glutaryl-CoA (at pH 7.6)
CC         {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663};
CC         KM=34.0 uM for glutaryl-CoA (at pH 8.5)
CC         {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663};
CC         Note=Release of crotonyl-CoA product from the enzyme is the
CC         rate-determining step in its steady-state turnover.;
CC   -!- PATHWAY: Amino-acid metabolism; lysine degradation.
CC   -!- PATHWAY: Amino-acid metabolism; tryptophan metabolism.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15274622,
CC       ECO:0000269|PubMed:18775954}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q92947-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q92947-2; Sequence=VSP_000145;
CC   -!- TISSUE SPECIFICITY: Isoform Long and isoform Short are expressed
CC       in fibroblasts and liver.
CC   -!- DISEASE: Glutaric aciduria 1 (GA1) [MIM:231670]: An autosomal
CC       recessive metabolic disorder characterized by progressive dystonia
CC       and athetosis due to gliosis and neuronal loss in the basal
CC       ganglia. {ECO:0000269|PubMed:14707522,
CC       ECO:0000269|PubMed:18775954, ECO:0000269|PubMed:24973495,
CC       ECO:0000269|PubMed:8541831, ECO:0000269|PubMed:8900227,
CC       ECO:0000269|PubMed:8900228, ECO:0000269|PubMed:9600243}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U69141; AAB08455.1; -; mRNA.
DR   EMBL; AF012342; AAC52079.1; -; Genomic_DNA.
DR   EMBL; AF012339; AAC52079.1; JOINED; Genomic_DNA.
DR   EMBL; AF012340; AAC52079.1; JOINED; Genomic_DNA.
DR   EMBL; AF012341; AAC52079.1; JOINED; Genomic_DNA.
DR   EMBL; BT006706; AAP35352.1; -; mRNA.
DR   EMBL; AK290407; BAF83096.1; -; mRNA.
DR   EMBL; AD000092; AAB51174.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84324.1; -; Genomic_DNA.
DR   EMBL; BC002579; AAH02579.1; -; mRNA.
DR   CCDS; CCDS12286.1; -. [Q92947-1]
DR   PIR; T44260; T44260.
DR   PIR; T45073; T45073.
DR   RefSeq; NP_000150.1; NM_000159.3. [Q92947-1]
DR   RefSeq; NP_039663.1; NM_013976.3. [Q92947-2]
DR   UniGene; Hs.532699; -.
DR   PDB; 1SIQ; X-ray; 2.10 A; A=47-438.
DR   PDB; 1SIR; X-ray; 2.60 A; A=45-438.
DR   PDB; 2R0M; X-ray; 2.70 A; A=45-438.
DR   PDB; 2R0N; X-ray; 2.30 A; A=45-438.
DR   PDBsum; 1SIQ; -.
DR   PDBsum; 1SIR; -.
DR   PDBsum; 2R0M; -.
DR   PDBsum; 2R0N; -.
DR   ProteinModelPortal; Q92947; -.
DR   SMR; Q92947; -.
DR   BioGrid; 108909; 18.
DR   IntAct; Q92947; 15.
DR   STRING; 9606.ENSP00000222214; -.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03245; S-4-Nitrobutyryl-Coa.
DR   iPTMnet; Q92947; -.
DR   PhosphoSitePlus; Q92947; -.
DR   DMDM; 2492631; -.
DR   EPD; Q92947; -.
DR   MaxQB; Q92947; -.
DR   PaxDb; Q92947; -.
DR   PeptideAtlas; Q92947; -.
DR   PRIDE; Q92947; -.
DR   DNASU; 2639; -.
DR   Ensembl; ENST00000222214; ENSP00000222214; ENSG00000105607. [Q92947-1]
DR   Ensembl; ENST00000591470; ENSP00000466845; ENSG00000105607. [Q92947-1]
DR   GeneID; 2639; -.
DR   KEGG; hsa:2639; -.
DR   UCSC; uc002mvq.5; human. [Q92947-1]
DR   CTD; 2639; -.
DR   DisGeNET; 2639; -.
DR   GeneCards; GCDH; -.
DR   HGNC; HGNC:4189; GCDH.
DR   HPA; HPA043252; -.
DR   HPA; HPA048492; -.
DR   MalaCards; GCDH; -.
DR   MIM; 231670; phenotype.
DR   MIM; 608801; gene.
DR   neXtProt; NX_Q92947; -.
DR   OpenTargets; ENSG00000105607; -.
DR   Orphanet; 25; Glutaryl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA28604; -.
DR   eggNOG; KOG0138; Eukaryota.
DR   eggNOG; COG1960; LUCA.
DR   GeneTree; ENSGT00760000119007; -.
DR   HOGENOM; HOG000131662; -.
DR   HOVERGEN; HBG001939; -.
DR   InParanoid; Q92947; -.
DR   KO; K00252; -.
DR   OMA; RCEDGCI; -.
DR   OrthoDB; EOG091G07GZ; -.
DR   PhylomeDB; Q92947; -.
DR   TreeFam; TF105051; -.
DR   BRENDA; 1.3.8.6; 2681.
DR   Reactome; R-HSA-71064; Lysine catabolism.
DR   SABIO-RK; Q92947; -.
DR   UniPathway; UPA00224; -.
DR   UniPathway; UPA00225; -.
DR   ChiTaRS; GCDH; human.
DR   EvolutionaryTrace; Q92947; -.
DR   GenomeRNAi; 2639; -.
DR   PRO; PR:Q92947; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105607; -.
DR   CleanEx; HS_GCDH; -.
DR   ExpressionAtlas; Q92947; baseline and differential.
DR   Genevisible; Q92947; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl.
DR   GO; GO:0004361; F:glutaryl-CoA dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:UniProtKB.
DR   GO; GO:0046949; P:fatty-acyl-CoA biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006554; P:lysine catabolic process; TAS:Reactome.
DR   GO; GO:0006568; P:tryptophan metabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; FAD; Flavoprotein; Glutaricaciduria; Mitochondrion;
KW   Oxidoreductase; Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     44       Mitochondrion. {ECO:0000255}.
FT   CHAIN        45    438       Glutaryl-CoA dehydrogenase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000000526.
FT   NP_BIND     177    186       FAD.
FT   NP_BIND     212    214       FAD.
FT   NP_BIND     387    391       FAD. {ECO:0000250}.
FT   NP_BIND     416    418       FAD.
FT   REGION      138    139       Substrate binding.
FT   REGION      287    294       Substrate binding.
FT   ACT_SITE    414    414       Proton acceptor. {ECO:0000305}.
FT   BINDING     186    186       Substrate; via carbonyl oxygen.
FT   BINDING     319    319       FAD. {ECO:0000250}.
FT   BINDING     330    330       FAD. {ECO:0000250}.
FT   BINDING     415    415       Substrate; via amide nitrogen.
FT   BINDING     434    434       FAD; via carbonyl oxygen.
FT   MOD_RES     240    240       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q60759}.
FT   VAR_SEQ     415    438       GTHDIHALILGRAITGIQAFTASK -> VVQMCSLKRRWNS
FT                                L (in isoform Short).
FT                                {ECO:0000303|PubMed:8541831}.
FT                                /FTId=VSP_000145.
FT   VARIANT      64     64       E -> D (in GA1).
FT                                {ECO:0000269|PubMed:24973495}.
FT                                /FTId=VAR_071510.
FT   VARIANT      88     88       R -> C (in GA1; dbSNP:rs142967670).
FT                                /FTId=VAR_000366.
FT   VARIANT      94     94       R -> L (in GA1).
FT                                /FTId=VAR_000367.
FT   VARIANT     101    101       G -> R (in GA1).
FT                                {ECO:0000269|PubMed:8900228}.
FT                                /FTId=VAR_000368.
FT   VARIANT     115    115       C -> Y (in GA1; dbSNP:rs776758971).
FT                                /FTId=VAR_000369.
FT   VARIANT     122    122       A -> V (in GA1; dbSNP:rs766325846).
FT                                /FTId=VAR_000370.
FT   VARIANT     128    128       R -> G (in GA1).
FT                                /FTId=VAR_000371.
FT   VARIANT     138    138       R -> G (in GA1; impaired protein
FT                                stability; loss of activity).
FT                                {ECO:0000269|PubMed:18775954}.
FT                                /FTId=VAR_000372.
FT   VARIANT     139    139       S -> L (in GA1; dbSNP:rs139851890).
FT                                /FTId=VAR_000373.
FT   VARIANT     148    148       V -> I (in GA1).
FT                                /FTId=VAR_000374.
FT   VARIANT     161    161       R -> Q (in GA1; dbSNP:rs777201305).
FT                                /FTId=VAR_000375.
FT   VARIANT     178    178       G -> R (in GA1; dbSNP:rs749452002).
FT                                /FTId=VAR_000376.
FT   VARIANT     179    179       L -> R (in GA1; dbSNP:rs774526353).
FT                                /FTId=VAR_000377.
FT   VARIANT     191    191       M -> T (in GA1; dbSNP:rs149120354).
FT                                /FTId=VAR_000378.
FT   VARIANT     195    195       A -> T (in GA1).
FT                                /FTId=VAR_000379.
FT   VARIANT     227    227       R -> P (in GA1; dbSNP:rs121434373).
FT                                /FTId=VAR_000380.
FT   VARIANT     236    236       F -> L (in GA1; dbSNP:rs747920711).
FT                                /FTId=VAR_000381.
FT   VARIANT     257    257       R -> Q (in GA1; dbSNP:rs751583656).
FT                                /FTId=VAR_000382.
FT   VARIANT     257    257       R -> W (in GA1; dbSNP:rs766518430).
FT                                /FTId=VAR_000383.
FT   VARIANT     263    263       M -> V (in GA1; severe phenotype;
FT                                residual activity of 30% as measured in
FT                                patient fibroblasts).
FT                                {ECO:0000269|PubMed:14707522}.
FT                                /FTId=VAR_060588.
FT   VARIANT     266    266       M -> V (in GA1).
FT                                /FTId=VAR_000384.
FT   VARIANT     268    268       G -> V (in GA1; dbSNP:rs765723076).
FT                                {ECO:0000269|PubMed:24973495}.
FT                                /FTId=VAR_071511.
FT   VARIANT     278    278       P -> S (in GA1; dbSNP:rs751742575).
FT                                /FTId=VAR_000385.
FT   VARIANT     283    283       L -> P (in GA1).
FT                                {ECO:0000269|PubMed:8900228}.
FT                                /FTId=VAR_000386.
FT   VARIANT     293    293       A -> T (in GA1; dbSNP:rs121434371).
FT                                {ECO:0000269|PubMed:8900228}.
FT                                /FTId=VAR_000387.
FT   VARIANT     294    294       R -> W (in GA1).
FT                                /FTId=VAR_000388.
FT   VARIANT     295    295       Y -> H (in GA1; dbSNP:rs121434366).
FT                                {ECO:0000269|PubMed:8541831}.
FT                                /FTId=VAR_000389.
FT   VARIANT     298    298       A -> T (in dbSNP:rs761765983).
FT                                /FTId=VAR_000390.
FT   VARIANT     298    298       A -> V (in dbSNP:rs764993096).
FT                                /FTId=VAR_000391.
FT   VARIANT     305    305       S -> L (in GA1).
FT                                {ECO:0000269|PubMed:8900228}.
FT                                /FTId=VAR_000392.
FT   VARIANT     308    308       C -> S (in GA1).
FT                                /FTId=VAR_000393.
FT   VARIANT     309    309       L -> W (in GA1).
FT                                /FTId=VAR_000394.
FT   VARIANT     313    313       R -> W (in GA1; dbSNP:rs779315456).
FT                                /FTId=VAR_000395.
FT   VARIANT     333    333       Q -> E (in GA1; dbSNP:rs794726972).
FT                                /FTId=VAR_000396.
FT   VARIANT     349    349       A -> T (in GA1).
FT                                /FTId=VAR_000397.
FT   VARIANT     354    354       G -> R (in GA1).
FT                                /FTId=VAR_000398.
FT   VARIANT     354    354       G -> S (in GA1; dbSNP:rs768925619).
FT                                /FTId=VAR_000399.
FT   VARIANT     355    355       R -> C (in GA1; dbSNP:rs781477694).
FT                                /FTId=VAR_000400.
FT   VARIANT     355    355       R -> H (in GA1; dbSNP:rs748275416).
FT                                /FTId=VAR_000401.
FT   VARIANT     365    365       E -> K (in GA1; dbSNP:rs121434370).
FT                                /FTId=VAR_000402.
FT   VARIANT     375    375       C -> R (in GA1).
FT                                {ECO:0000269|PubMed:24973495}.
FT                                /FTId=VAR_000403.
FT   VARIANT     382    382       A -> T (in GA1; dbSNP:rs567564095).
FT                                /FTId=VAR_000404.
FT   VARIANT     383    383       R -> C (in GA1; dbSNP:rs150938052).
FT                                /FTId=VAR_000405.
FT   VARIANT     383    383       R -> H (in GA1; dbSNP:rs764608975).
FT                                /FTId=VAR_000406.
FT   VARIANT     386    386       R -> Q (in GA1; dbSNP:rs398123190).
FT                                /FTId=VAR_000407.
FT   VARIANT     390    390       G -> A (in GA1).
FT                                /FTId=VAR_000409.
FT   VARIANT     390    390       G -> R (in GA1; dbSNP:rs372983141).
FT                                {ECO:0000269|PubMed:8900228}.
FT                                /FTId=VAR_000408.
FT   VARIANT     392    392       N -> D (in GA1).
FT                                /FTId=VAR_000410.
FT   VARIANT     400    400       V -> M (in GA1; dbSNP:rs121434372).
FT                                /FTId=VAR_000411.
FT   VARIANT     402    402       R -> Q (in GA1; dbSNP:rs786204626).
FT                                /FTId=VAR_000413.
FT   VARIANT     402    402       R -> W (in GA1; most common mutation
FT                                identified; loss of tetramerization; loss
FT                                enzyme activity; dbSNP:rs121434369).
FT                                {ECO:0000269|PubMed:18775954,
FT                                ECO:0000269|PubMed:24973495}.
FT                                /FTId=VAR_000412.
FT   VARIANT     403    403       H -> R (in GA1).
FT                                /FTId=VAR_000414.
FT   VARIANT     406    406       N -> K (in GA1).
FT                                /FTId=VAR_000415.
FT   VARIANT     407    407       L -> P (in GA1).
FT                                /FTId=VAR_000416.
FT   VARIANT     414    414       E -> K (in GA1; loss of enzyme activity;
FT                                dbSNP:rs147611168).
FT                                {ECO:0000269|PubMed:18775954}.
FT                                /FTId=VAR_000417.
FT   VARIANT     416    416       T -> I (in GA1; dbSNP:rs121434368).
FT                                {ECO:0000269|PubMed:8900228}.
FT                                /FTId=VAR_000418.
FT   VARIANT     421    421       A -> T (in GA1; dbSNP:rs151201155).
FT                                /FTId=VAR_000419.
FT   VARIANT     421    421       A -> V (in GA1; impaired association of
FT                                subunits; dbSNP:rs121434367).
FT                                /FTId=VAR_000420.
FT   VARIANT     429    429       T -> M (in GA1; dbSNP:rs745360675).
FT                                {ECO:0000269|PubMed:24973495}.
FT                                /FTId=VAR_000421.
FT   VARIANT     433    433       A -> E (in GA1).
FT                                /FTId=VAR_000422.
FT   MUTAGEN     414    414       E->D: Reduced catalytic activity.
FT   CONFLICT     33     33       G -> A (in Ref. 1; AAC52079).
FT                                {ECO:0000305}.
FT   HELIX        56     59       {ECO:0000244|PDB:1SIQ}.
FT   HELIX        62     78       {ECO:0000244|PDB:1SIQ}.
FT   HELIX        80     89       {ECO:0000244|PDB:1SIQ}.
FT   HELIX        95    102       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       120    131       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       135    146       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       149    155       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       158    169       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      175    178       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      184    186       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       188    190       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      194    198       {ECO:0000244|PDB:1SIQ}.
FT   TURN        199    202       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      203    214       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       216    218       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      220    228       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      233    239       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      254    256       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      261    272       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       273    275       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       284    318       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       326    328       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       330    358       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       364    388       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       389    394       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       396    398       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       400    410       {ECO:0000244|PDB:1SIQ}.
FT   STRAND      413    415       {ECO:0000244|PDB:1SIQ}.
FT   HELIX       417    429       {ECO:0000244|PDB:1SIQ}.
SQ   SEQUENCE   438 AA;  48127 MW;  415B8D510027BB63 CRC64;
     MALRGVSVRL LSRGPGLHVL RTWVSSAAQT EKGGRTQSQL AKSSRPEFDW QDPLVLEEQL
     TTDEILIRDT FRTYCQERLM PRILLANRNE VFHREIISEM GELGVLGPTI KGYGCAGVSS
     VAYGLLAREL ERVDSGYRSA MSVQSSLVMH PIYAYGSEEQ RQKYLPQLAK GELLGCFGLT
     EPNSGSDPSS METRAHYNSS NKSYTLNGTK TWITNSPMAD LFVVWARCED GCIRGFLLEK
     GMRGLSAPRI QGKFSLRASA TGMIIMDGVE VPEENVLPGA SSLGGPFGCL NNARYGIAWG
     VLGASEFCLH TARQYALDRM QFGVPLARNQ LIQKKLADML TEITLGLHAC LQLGRLKDQD
     KAAPEMVSLL KRNNCGKALD IARQARDMLG GNGISDEYHV IRHAMNLEAV NTYEGTHDIH
     ALILGRAITG IQAFTASK
//
